Skip to main navigation Skip to search Skip to main content

Phase II Trial of Oral Etoposide in Recurrent or Refractory Endometrial Adenocarcinoma: A Southwest Oncology Group Study

  • Elizabeth A. Poplin
  • , P.Y. Liu
  • , James E. Delmore
  • , Sharon Wilczynski
  • , Dennis F. Moore
  • , Ronald K. Potkul
  • , Bruce A. Fine
  • , Edward V. Hannigan
  • , David S. Alberts
  • Cancer Center of New Jersey, New Brunswick, New Jersey, 08901
  • Southwest Oncology Group Statistical Center, Seattle, Washington, 98109
  • University of Kansas
  • City of Hope National Medical Center
  • Wichita CCOP, Wichita, Kansas, 67214
  • Loyola University Chicago
  • University of Texas Health Science Center at San Antonio
  • University of Texas Medical Branch
  • University of Arizona

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalGynecologic Oncology
Volume74
Issue number3
DOIs
StatePublished - Sep 1 1999
Externally publishedYes

Disciplines

  • Medicine and Health Sciences
  • Oncology
  • Internal Medicine

Cite this